With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Blockade of Mycn in neuroblastoma||University of California San Francisco / William Weiss||Innovation Grants||2008||California|
|131-I-MIBG and Targeted Therapy for Neuroblastoma: Infrastructure Proposal.||University of California San Francisco / Katherine Matthay, MD||Phase I/II Infrastructure Grants||2007||California|
|Long-Term Morbidity in Survivors of Childhood Cancer with Down Syndrome||University of California San Francisco / Shannon Raber||Nurse Researcher Grants||2010||California|
|Alternative Splicing Driven by MYCN Activates RAS-MAPK in Neuroblastoma||University of California San Francisco / William Weiss, MD/PhD||Innovation Grants||2018||California|
|Investigation of Genetic and Molecular Mechanisms of Second Malignant Neoplasms in a Mouse Model||University of California San Francisco / Jean Nakamura||Young Investigator Grants||2011||California|
|Identifying novel biomarkers for risk stratification in t-cell acute lymphoblastic leukemia (ALL).||University of California San Francisco / Michelle Hermiston, MD, PhD||Young Investigator Grants||2009||California|
|Optimizing EGFR targeted therapy in pediatric malignant glioma.||University of California San Francisco / Theodore Nicolaides||Young Investigator Grants||2009||California|
|In-vivo characterization of MYCN-driven immunosuppression||University of California San Francisco / William Weiss, MD/PhD||Innovation Grants||2021||California|
|Blockade of MYCN in neuroblastoma||University of California San Francisco / William Weiss, MD/PhD||Innovation Grants||2011||California|
|Targeting inhibitory phosphatase signaling in high-risk childhood ALL||University of California San Francisco / Markus Muschen, MD, PhD||Innovation Grants||2011||California|